There are 1,600 ANDA’s pending at the FDA, twice as many as in 2005 (see below). Meanwhile, the number of reviewers in the FDA’s Office of Generic Drugs has barely increased. <img src=http://208.78.96.220/generic_backlog.gif> Related articles: <a href='read_msg.asp?message_id=9591568'>#msg-9591568</a>, <a href='read_msg.asp?message_id=23423947'>#msg-23423947</a>. (Source for 1,600 figure: Sandoz)